Li, Ying-Ying <br/><br/>
Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression.  [electronic resource] 

 -  Anti-cancer drugs  Jan 2011 
 - 89-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e3283400a05  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma of Lung<br/>Animals<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--biosynthesis<br/>Cyclin-Dependent Kinase Inhibitor p27--biosynthesis<br/>Cyclin-Dependent Kinases--biosynthesis<br/>Cyclins--biosynthesis<br/>Diphosphonates--antagonists & inhibitors<br/>Diterpenes--pharmacology<br/>Down-Regulation--drug effects<br/>E2F Transcription Factors--metabolism<br/>Imidazoles--antagonists & inhibitors<br/>Lung Neoplasms--drug therapy<br/>Mevalonic Acid--metabolism<br/>Mice<br/>Mice, Inbred BALB C<br/>Phosphorylation--drug effects<br/>Protein Transport--drug effects<br/>Retinoblastoma Protein--metabolism<br/>Zoledronic Acid<br/>ras Proteins--antagonists & inhibitors